Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
NCT02288910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2020-10-08
Summary
This project investigates the feasibility of assessing the relative blood volume of carcinomas in patients with Hepatocellular Carcinoma (HCC) and liver metastases from pancreatic or colorectal cancer compared to normal liver from DynaCT acquisitions on an interventional platform.
Conditions
- Hepatocellular Carcinoma
- Metastatic Carcinoma to the Liver
Sponsors & Collaborators
-
Rush University Medical Center
lead OTHER
Principal Investigators
-
Mark Supanich, PH.D. · Rush University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2019-07-31
- Completion
- 2020-07-31
Countries
- United States
Study Locations
More Related Trials
-
ctDNA Monitoring in Patients With HCC and mCRC
NCT07001085 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients
NCT02587793 ·Status: COMPLETED
-
LEAF(Liver Tumor dEtection And classiFication AI)
NCT06859840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
NCT06899854 ·Status: RECRUITING
-
Retrospective Clinical Validation of HepatoPredict
NCT06894524 ·Status: NOT_YET_RECRUITING
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Hepatocellular Cancer (HCC) Screening in Zhongshan City
NCT02501980 ·Status: UNKNOWN
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Prospective Post Y90 Liver Hypertrophy
NCT02783261 ·Status: UNKNOWN
-
Epidemiologic Study of Hepatocellular Carcinoma in the US
NCT02358070 ·Status: COMPLETED
-
Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma
NCT05458115 ·Status: UNKNOWN
-
Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications
NCT02936856 ·Status: UNKNOWN ·Phase: NA
-
Hepatobiliary Tumors Tissue Samples Acquisition
NCT04445532 ·Status: UNKNOWN
-
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150 ·Status: RECRUITING
-
A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma
NCT07265271 ·Status: RECRUITING
-
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma
NCT03892681 ·Status: UNKNOWN ·Phase: NA
-
CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma
NCT04715321 ·Status: UNKNOWN
-
Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular Carcinoma
NCT05235490 ·Status: COMPLETED
-
Extracellular RNA Markers of Liver Disease and Cancer
NCT02908048 ·Status: TERMINATED
-
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
NCT01316679 ·Status: COMPLETED
-
CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization
NCT03990623 ·Status: UNKNOWN ·Phase: NA
-
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
NCT05719480 ·Status: RECRUITING